FRSH
Freshworks Inc.
FRSH's outlook is improving, though it still trails on the overall score.
MU
Micron Technology, Inc.
MU has the edge over FRSH overall, supported by stronger valuation and stronger modeled upside.
FRSH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Strong |
FRSH's revenue, profitability, cash flow and balance sheet are all currently healthy.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
FRSH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 13x | $9.39 | -26% |
| Forward | 15x | $12.67 | — |
| Fair | 16x | $11.78 | -7.1% |
| Current | 18x | $12.67 | — |
| Expensive | 20x | $14.57 | +15% |
Historical ranges are pointers, not guarantees.
FRSH has the edge over MU in the historical PE scenario, which offers more potential upside but is not a forecast.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
FRSH Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for FRSH, with profitability improving.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
FRSH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.84 | +17% |
| Q3 2026 | $0.72 | +$0.82 |
| Q2 2026 | $0.63 | +$0.81 |
| Q1 2026 | $0.61 | +$0.85 |
| Q4 2025 | $0.63 | +$0.95 |
| Q3 2025 | -$0.10 | +$0.24 |
| Q2 2025 | -$0.18 | +$0.17 |
| Q1 2025 | -$0.24 | +$0.16 |
| Q4 2024 | -$0.32 | +$0.15 |
FRSH has returned to profit: it earned $0.72 per share over the past year, after losing money the year before.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU's earnings per share have climbed steadily: $74.33 over the past year, about 10 times what it earned the year before, and higher year over year for 10 quarters in a row.
FRSH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $245.4M | +14% |
| Q2 2026 | $237.4M | +16% |
| Q1 2026 | $228.6M | +16% |
| Q4 2025 | $222.7M | +14% |
| Q3 2025 | $215.1M | +15% |
| Q2 2025 | $204.7M | +18% |
| Q1 2025 | $196.3M | +19% |
| Q4 2024 | $194.6M | +22% |
FRSH's revenue has grown year over year every quarter since late 2020: $245M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | +15 points |
| Q2 2026 | 2.5% | +6.8 points |
| Q1 2026 | -3.5% | +1.8 points |
| Q4 2025 | 18% | +30 points |
| Q3 2025 | -3.5% | +17 points |
| Q2 2025 | -4.2% | +21 points |
| Q1 2025 | -5.3% | +14 points |
| Q4 2024 | -12% | +13 points |
FRSH's operating margin was 12% last quarter, up 15 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over FRSH on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over FRSH on profitability, with a higher operating margin.
FRSH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $74.9M | +21% |
| Q2 2026 | $53.5M | -8.1% |
| Q1 2026 | $58.5M | +3.2% |
| Q4 2025 | $60.1M | +66% |
| Q3 2025 | $61.7M | +49% |
| Q2 2025 | $58.2M | +71% |
| Q1 2025 | $56.7M | +42% |
| Q4 2024 | $36.3M | +22% |
FRSH generated $247M in free cash flow over the past year, up 16% from the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU generated $59B in free cash flow over the past year, more than ten times what it generated the year before.
FRSH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.4% | -6.6M shares |
| 1 year | -6.9% | -19.8M shares |
| 3 years | -9.4% | -27.8M shares |
| 5 years | +5.3% | +13.5M shares |
| Available history | +1468% | +249M shares |
FRSH has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $27.2M |
| Q2 2026 | $159M |
| Q1 2026 | $48.4M |
| Q4 2025 | — |
| Q3 2025 | $159.1M |
| Q2 2025 | $113.6M |
| Q1 2025 | $113.6M |
| Q2 2021 | — |
FRSH spent $235M buying back its own shares over the past year.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
FRSH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.8x | Net Cash |
| Q2 2026 | -8.3x | Net Cash |
| Q1 2026 | -12.8x | Net Cash |
| Q4 2025 | -14.6x | Net Cash |
| Q2 2021 | -122.9x | Net Cash |
| Q1 2021 | -101.8x | Net Cash |
| Q1 2019 | 6.2x | High |
FRSH has the edge over MU on leverage, with a lower net debt burden relative to earnings.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
FRSH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.8 | Neutral |
| Stochastic | 46.5 | Neutral |
FRSH's weekly RSI is 53 (neutral) and its Stochastic is 47 (neutral).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
FRSH PE vs Technology Sector
| Metric | FRSH | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 28x | 37% below |
| PE % | 62 | 45 | 17 pts above |
FRSH is trading at 18x earnings, a 37% discount to the Technology sector's median of 28x, though its earnings don't support one.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over FRSH on valuation relative to its sector.
FRSH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.5 | 6.1% below |
| 20 week MA | $12.5 | 1.6% above |
| 50 week MA | $10.8 | 18% above |
| 100 week MA | $12.5 | 1.4% above |
| 200 week MA | $14.5 | 13% below |
FRSH's trend is mixed: it's above three of its five weekly moving averages, and 13% below its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
FRSH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $46.8 | $27.9 | -40% |
| 2022 | $27.9 | $13.8 | -50% |
| 2023 | $13.8 | $23.5 | +70% |
| 2024 | $23.5 | $15.9 | -32% |
| 2025 | $15.9 | $12.4 | -22% |
| 2026 YTD | $12.4 | $12.7 | +2.2% |
FRSH has finished lower in four of the last five years. It's up 2.2% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over FRSH on returns for 2026, with the stronger performance.